crypto currency cost Featured

It is said that Li Zhenyu, senior vice president of Baidu Group, left his post. According to media reports, Li Zhenyu, senior vice president of Baidu Group, assistant to CEO and former general manager of intelligent driving business group, has left his post. At present, no personal information can be found in the internal system. Sina Technology asked Baidu Group about this. As of press time, there is no official response. (Sina Technology)Hongya CNC: The income from exporting products to the US market is relatively low. Hongya CNC (002833) said on the interactive platform today that the company's products are exported to more than 70 countries and regions, and the income from the US market is relatively low.Australia's S&P/ASX 200 index closed at 8399.40 points, down 0.28%.

Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.Reserve Bank of Australia President Brock: The change in wording of the central bank's monetary policy committee is intentional. Reserve Bank of Australia President Brock: The change in wording of the statement is intentional. The Committee noted that the data had weakened. Have more confidence in inflation. The Committee believes that the economic situation is basically in line with expectations. No need for two or more quarterly inflation data to change. Will pay attention to all data including employment.Afternoon comment: The Shanghai Composite Index rose more than 1% in half a day, and consumer concept stocks broke out collectively. The index was active in early trading. The Shanghai Composite Index rose more than 1% in half a day, and the Shanghai Composite Index rose more than 2%. In terms of sectors, robot concept stocks continued to break out, and the concept of PEEK materials led the rise. Both China Research Institute and Xinyi New Materials had a daily limit of 20cm, while Zhongxin Fluorescent Materials and Walter shares touched the daily limit; The large consumer sector collectively rose, with dairy stocks leading the gains, and Panda Dairy, Western Animal Husbandry and Li Ziyuan were trading daily; AI concept stocks fluctuated higher, and it is worth buying 20cm daily limit, Hanwang Technology, Xinhua Media and other daily limit; Insurance stocks strengthened, and Tianli Technology, Astar, Focus Technology and other daily limit. Overall, individual stocks showed a general upward trend, with more than 4,600 stocks rising. On the disk, all sectors in the two cities generally rose, with PEEK materials, film and television theaters and dairy sectors among the top gainers.

Hongya CNC: The income from exporting products to the US market is relatively low. Hongya CNC (002833) said on the interactive platform today that the company's products are exported to more than 70 countries and regions, and the income from the US market is relatively low.Broad-based index products are expected to increase the Y share of personal pension, and personal pension products are expected to expand after the second anniversary of the personal pension system. It is understood that mainstream broad-based index products are expected to increase the personal pension Y share, including Shanghai and Shenzhen 300 Index, CSI 500 Index, CSI A500 Index, GEM Index and other products, which can provide investors with more allocation needs. (SSE)Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.